1. RODNA
  2. CONICET
  3. CONICET
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorMaarouf, Chera L.-
dc.creatorDaugs, Ian D.-
dc.creatorKokjohn, Tyler A.-
dc.creatorWalker, Douglas G.-
dc.creatorHunter, Jesse M.-
dc.creatorKruchowsky, Jane C.-
dc.creatorWoltjer, Randy-
dc.creatorKaye, Jeffrey-
dc.creatorCastaño, Eduardo Miguel-
dc.creatorSabbagh, Marwan N.-
dc.creatorBeach, Thomas G.-
dc.creatorRoher, Alex E.-
dc.date2017-03-14T14:10:06Z-
dc.date2017-03-14T14:10:06Z-
dc.date2011-
dc.date2017-02-07T13:52:01Z-
dc.date.accessioned2019-04-29T15:57:12Z-
dc.date.available2019-04-29T15:57:12Z-
dc.identifierMaarouf, Chera L.; Daugs, Ian D.; Kokjohn, Tyler A.; Walker, Douglas G.; Hunter, Jesse M.; et al.; Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging; Public Library Of Science; Plos One; 6; 11; -1-2011; 1-17-
dc.identifier1932-6203-
dc.identifierhttp://hdl.handle.net/11336/13820-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/306102-
dc.descriptionThe amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is the prime instigator of neurotoxicity and dementia, specific protective mechanisms must enable these HPC to evade cognitive decline. We evaluated the neuropathological and biochemical differences existing between non-demented (ND)-HPC and an age-matched cohort with AD dementia. The ND-HPC selected for our study were clinically assessed as ND and possessed high amyloid plaque burdens. ELISA and Western blot analyses were used to quantify a group of proteins related to APP/Aβ/tau metabolism and other neurotrophic and inflammation-related molecules that have been found to be altered in neurodegenerative disorders and are pivotal to brain homeostasis and mental health. The molecules assumed to be critical in AD dementia, such as soluble or insoluble Aβ40, Aβ42 and tau were quantified by ELISA. Interestingly, only Aβ42 demonstrated a significant increase in ND-HPC when compared to the AD group. The vascular amyloid load which was not used in the selection of cases, was on the average almost 2-fold greater in AD than the ND-HPC, suggesting that a higher degree of microvascular dysfunction and perfusion compromise was present in the demented cohort. Neurofibrillary tangles were less frequent in the frontal cortices of ND-HPC. Biochemical findings included elevated vascular endothelial growth factor, apolipoprotein E and the neuroprotective factor S100B in ND-HPC, while anti-angiogenic pigment epithelium derived factor levels were lower. The lack of clear Aβ-related pathological/biochemical demarcation between AD and ND-HPC suggests that in addition to amyloid plaques other factors, such as neurofibrillary tangle density and vascular integrity, must play important roles in cognitive failure.-
dc.descriptionFil: Maarouf, Chera L.. Banner Sun Health Research Institute. The Longtine Center for Neurodegenerative Biochemistry; Estados Unidos-
dc.descriptionFil: Daugs, Ian D.. Banner Sun Health Research Institute. The Longtine Center for Neurodegenerative Biochemistry; Estados Unidos-
dc.descriptionFil: Kokjohn, Tyler A.. Banner Sun Health Research Institute. The Longtine Center for Neurodegenerative Biochemistry; Estados Unidos. Midwestern University; Estados Unidos-
dc.descriptionFil: Walker, Douglas G.. Banner Sun Health Research Institute. Laboratory of Neuroinflammation; Estados Unidos-
dc.descriptionFil: Hunter, Jesse M.. Banner Sun Health Research Institute. The Longtine Center for Neurodegenerative Biochemistry; Estados Unidos-
dc.descriptionFil: Kruchowsky, Jane C.. Banner Sun Health Research Institute. Laboratory of Neuroinflammation; Estados Unidos-
dc.descriptionFil: Woltjer, Randy. Oregon Health & Science University. Department of Pathology; Estados Unidos-
dc.descriptionFil: Kaye, Jeffrey. Oregon Health and Science University. Layton Aging and Alzheimer’s Disease Center; Estados Unidos-
dc.descriptionFil: Castaño, Eduardo Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina. Fundación Instituto Leloir; Argentina-
dc.descriptionFil: Sabbagh, Marwan N.. Banner Sun Health Research Institute. Cleo Roberts Center for Clinical Research; Estados Unidos-
dc.descriptionFil: Beach, Thomas G.. Banner Sun Health Research Institute. Civin Laboratory for Neuropathology; Estados Unidos-
dc.descriptionFil: Roher, Alex E.. Banner Sun Health Research Institute. The Longtine Center for Neurodegenerative Biochemistry; Estados Unidos-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherPublic Library Of Science-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027291-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.pone.0027291-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.subjectAlzheimer's disease-
dc.subjectAging-
dc.subjectneuropathology-
dc.subjectnonagenarians-
dc.subjectNeurociencias-
dc.subjectMedicina Básica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleAlzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro sencillo del ítem